These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11771428)

  • 21. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C; Licht J; Roessner A; Carl-McGrath S
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological variation and reference change values of CA 19-9, CEA, AFP in serum of healthy individuals.
    Erden G; Barazi AO; Tezcan G; Yildirimkaya MM
    Scand J Clin Lab Invest; 2008; 68(3):212-8. PubMed ID: 17926198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlling data quality and reproducibility of a high-sensitivity immunoassay using isotachophoresis in a microchip.
    Park CC; Kazakova I; Kawabata T; Spaid M; Chien RL; Wada HG; Satomura S
    Anal Chem; 2008 Feb; 80(3):808-14. PubMed ID: 18173249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the clinical use of alpha-fetoprotein (AFP) colloidal gold diagnostic strip].
    Jiang XM; Kong J; Lin T; Yu XY; Chen Y; Dai Y; Yang HY; Sun XL; Yang J; Yang YQ; Zhang YC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):210-2. PubMed ID: 12816714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Standards, options and recommendations for tumor markers in colorectal cancer].
    Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
    Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
    Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
    Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
    J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia.
    Shami VM; Sundaram V; Stelow EB; Conaway M; Moskaluk CA; White GE; Adams RB; Yeaton P; Kahaleh M
    Pancreas; 2007 May; 34(4):466-9. PubMed ID: 17446847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
    Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J
    Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
    Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
    Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.
    Christoforidis A; Lefkou E; Vlachaki E; Perifanis V; Tsatra I; Dogramatzi F; Athanassiou-Metaxa M
    Ann Hematol; 2007 Nov; 86(11):837-41. PubMed ID: 17668208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of 2 tumor markers (alpha-fetoprotein and carcinoembryonic antigen) in the serum by a new immunonephelometric technique].
    Gray H; Sauger F; Maitrot B
    Ann Biol Clin (Paris); 1997; 55(6):597-600. PubMed ID: 9499921
    [No Abstract]   [Full Text] [Related]  

  • 35. [Criteria for the use of tumor markers. 1: Quality assurance--characteristics of the most important tumor markers].
    Fateh-Moghadam A; Stieber P
    Fortschr Med; 1996 Feb; 114(6):30-3. PubMed ID: 8900526
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.
    Molina R; Filella X; Zanon G; Pahisa J; Alicarte J; Munoz M; Farrus B; Ballesta AM
    Anticancer Res; 2003; 23(2A):1043-50. PubMed ID: 12820345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
    Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
    Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
    Kumar Y; Tapuria N; Kirmani N; Davidson BR
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.